Skip to main content
Fig. 3 | Thrombosis Journal

Fig. 3

From: Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials

Fig. 3

Levels of coagulation biomarkers. a D-dimer; b Prothrombin fragments 1 + 2 (F1+2); c Soluble fibrin monomer complex (SFMC). Open circles mark mean; horizontal lines indicate median; boxes represent 25–75%; capped lines represent 10 and 90%; * = P <0.001 (Wilcoxon test)

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us